Harini Subbiah is a Senior Research Associate at Ultragenyx Pharmaceutical Inc. , focusing on AAV-based gene therapy for Duchenne Muscular Dystrophy. A molecular biologist with a Masters from the University at Buffalo, she is experienced in optimizing and executing a variety of molecular and cell-based analytical assays.
Her research background includes significant work on fungal genetics and the immunopathogenesis of CNS infections. She has published research on the human fungal pathogen *Cryptococcus neoformans*.
Unique fact: Harini has co-authored multiple publications investigating post-transcriptional regulation and drug resistance in *Cryptococcus neoformans*.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.